Sir -Our primary purpose was to develop a consistent model based on Swedish statistics to describe the natural history of cervical neoplasia from the time when the patient develops cancer in situ (CIS) up to the time of death (Gustafsson & Adanmi, 1989 Adami, 1989) we stated that 80% is 'typical' although we said the figure ranged between 77% and 85% since it varies with age.)
In model terms these statements all question whether the rates of cancer in situ in Sweden are correct. The incidence rates of invasive cancer and the mortality rates in countries like Holland, the UK and Canada are rather similar to those in Sweden for the period studied (Canadian Task Force on Screening, 1976) . But the in situ figures are several times higher in Sweden than estimates from corresponding countries. In Sweden about 4,000 cases of cancer in situ are reported annually; this figure should be compared to the reported number of cases of invasive cancer, which has decreased from about 800 before screening to about 500 per year in 1985 (National Welfare, 1960-1984) . A dynamic model and birth cohort figures are needed for accurate calculations, but it seems obvious that the vast majority of cases of cancer in situ would not have progressed to invasive cancer if they had not been detected.
Although nobody has yet succeeded in explaining the discrepancy between the rates of cancer in situ in Sweden and in other countries, we belive that there are some factors which may be involved. One factor may be the current method of classifying cancer in situ. In Sweden severe dysplasia on the borderline to cancer in situ must by law be reported and such cases are classified as cancer in situ in the Swedish Cancer Registry Welfare, 1960-1984 (Gustafsson & Adami, 1989 ) -would have smaller values (but the same shape), the proportional parameter P would be larger, and the prevalence rates would be smaller. The rest of the results, e.g. the mean duration of CIS, would be the same, as also would the course of the effect of age, since the incidence of invasive cancer and the mortality rates are not affected. The absence of age dependency would still be valid.
Van Oortmarssen and Habbema also suggest a comparison with empirical data obtained from prevalence screening and repeated screening in Sweden. However, a comparison is difficult to make because of the lack of registrations, questions concerning sensitivity and the fact that Pap smears are often used to estimate the number of cancer in situ. For the same reasons, accurate estimates cannot be made from repeated screening. The best information available is provided by the gynaecological mass examinations in 1967-68 (National Board of Health and Welfare, 1970) , in which the results agreed will with those from our model. Thus, at ages 30-45 years, detection rates of cancer in situ of 19 per 1,000 for 1967 (of the 7,411 women examined) and 28 per 1,000 for 1968 (of the 40,800 women examined) were found, compared to a prevalence of 32 per 1,000 in our model estimates.
Other data referred to by van Oortmarssen and Habbema (Bjerre, 1969; Kjellgren, 1977) concern small regions in the country where there is a 13.5 times difference between the southern and the northern parts of Sweden. Since the agestandardised rates of invasive cancer differ only two-fold between these areas, it is unlikely that both of these estimates of prevalence are correct. In fact, there is clear evidence that the study of Bjerre (1969) , but not that of Kjellgren (1977) , represents prevalence screening. It is unlikely that a high prevalence of hysterectomy has substantially biased our estimates of the natural history of cervical neoplasia. As previously reported by Pettersson et al. (1985) : 'Hysterectomy played a minor role in Sweden and was never a standard method for treatment of in situ carcinoma. Thus the number of uteri at risk is not significantly different from the number of women at risk. ' We have recently estimated the prevalence of hysterectomy to be about 7% in a population sample of women aged 60 years or more (Naessen et al., 1990) . Since there is no exact information available about the prevalence of hysterectomy in different age groups, we chose to use the number of women instead of the women at risk. Our definitions strictly follow this choice.
Yours etc.,
